BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35708328)

  • 1. Mixed B- and T-lymphocyte Vitreous Infiltrate in Multiple Sclerosis Associated Uveitis.
    Khalid S; Sharma G; Jakati S; Basu S
    Ocul Immunol Inflamm; 2023 Jul; 31(5):996-998. PubMed ID: 35708328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis).
    Davis JL; Ruiz P; Shah M; Mandelcorn ED
    Trans Am Ophthalmol Soc; 2012 Dec; 110():117-29. PubMed ID: 23818738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study.
    Maruyama K; Inaba T; Sugita S; Ichinohasama R; Nagata K; Kinoshita S; Mochizuki M; Nakazawa T
    BMJ Open; 2017 Nov; 7(11):e014549. PubMed ID: 29150462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pars plana vitrectomy in the diagnosis and treatment of uveitis.
    Svozilkova P; Heissigerova J; Brichova M; Kalvodova B; Dvorak J; Rihova E
    Eur J Ophthalmol; 2011; 21(1):89-97. PubMed ID: 20853259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis.
    Kojima K; Maruyama K; Inaba T; Nagata K; Yasuhara T; Yoneda K; Sugita S; Mochizuki M; Kinoshita S
    Ophthalmology; 2012 Nov; 119(11):2386-92. PubMed ID: 22809758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pars plana vitrectomy for vitreous opacity associated with ocular sarcoidosis resistant to medical treatment.
    Ieki Y; Kiryu J; Kita M; Tanabe T; Tsujikawa A; Yamashiro K; Miyamoto N; Miura S; Honda Y
    Ocul Immunol Inflamm; 2004 Mar; 12(1):35-43. PubMed ID: 15209462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic pars plana vitrectomy and aqueous analyses in patients with uveitis of unknown cause.
    Oahalou A; Schellekens PA; de Groot-Mijnes JD; Rothova A
    Retina; 2014 Jan; 34(1):108-14. PubMed ID: 23619637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binocular indirect ophthalmo microscope-assistant gas-perfused pars plana vitrectomy: A novel technique for vitreous sample acquisition.
    Zhang L; Yang X; Zheng Q; Wu M
    Medicine (Baltimore); 2016 Dec; 95(49):e5503. PubMed ID: 27930538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hypertensive uveitis as the first presentation of multiple sclerosis.
    Shields MK; Simon S; Chan W; Gilhotra JS
    Indian J Ophthalmol; 2019 Jan; 67(1):163-164. PubMed ID: 30574934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive non-inflammatory lesions of the vitreous and intermediate uveitis].
    Caspers-Velu LE; Libert J
    Bull Soc Belge Ophtalmol; 1995; 255():49-53. PubMed ID: 7496575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pars plana vitrectomy in the management of intraocular inflammation.
    Algvere P; Alanko H; Dickhoff K; Lähde Y; Saari KM
    Acta Ophthalmol (Copenh); 1981 Oct; 59(5):727-36. PubMed ID: 6976057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery.
    Bansal R; Dogra M; Chawla R; Kumar A
    Indian J Ophthalmol; 2020 Sep; 68(9):1844-1851. PubMed ID: 32823401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Outcome of Microincision Vitreous Surgery in Uveitis.
    Bansal R; Gupta A; Gupta V; Mulkutkar S; Dogra M; Katoch D; Dogra MR; Sharma K; Singh MP; Sharma A; Kamal S; Sharma SP
    Ocul Immunol Inflamm; 2017 Dec; 25(6):775-784. PubMed ID: 27191861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.
    Coric D; Ometto G; Montesano G; Keane PA; Balk LJ; Uitdehaag BMJ; Petzold A; Crabb DP; Denniston AK
    Eur J Neurol; 2020 Jan; 27(1):144-e3. PubMed ID: 31342606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pars plana vitrectomy in patients with intermediate uveitis.
    Stavrou P; Baltatzis S; Letko E; Samson CM; Christen W; Foster CS
    Ocul Immunol Inflamm; 2001 Sep; 9(3):141-51. PubMed ID: 11815883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Profiling of T Cells Infiltrating Vitreous Humor in Tubercular Uveitis.
    Sharma RK; Gupta V; Bansal R; Sharma K; Gupta A; Sachdeva N
    Immunol Invest; 2018 Aug; 47(6):615-631. PubMed ID: 29733740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Aqueous and Vitreous Lymphocyte Populations From Two Rat Models of Experimental Uveitis.
    Pepple KL; Wilson L; Van Gelder RN
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2504-2511. PubMed ID: 29847657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pars plana vitrectomy. Vitrectomy treatment of vitreous opacities.
    Peyman GA; Huamonte FU; Goldberg MF
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(3 Pt 1):394-8. PubMed ID: 960361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of diagnostic and therapeutic pars plana vitrectomy in endogenous uveitis].
    Ríhová E; Sisková A; Jandusová J; Dotrelová D; Diblík P; Sach J
    Cesk Slov Oftalmol; 2003 Nov; 59(6):373-80. PubMed ID: 14740382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of epiretinal proliferative cellular tissue from a patient with sarcoidosis.
    Fukushima A; Hashida M; Hayashi N; Hiroi M; Ueno H
    Jpn J Ophthalmol; 2002; 46(6):675-8. PubMed ID: 12543197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.